• Exchange: Munich
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

OC5:GR

50.081 EUR 1.488 3.06%

As of 08:40:32 ET on 12/19/2014.

Snapshot for Cochlear Ltd (OC5)

Open: 50.120 Day's Range: 49.815 - 50.120 Volume: 0
Previous Close: 48.593 52wk Range: 34.980 - 51.810 1-Yr Rtn: +39.25%

Stock Chart for OC5

No chart data available.
  • OC5:GR 50.006
  • 1D
  • 1M
  • 1Y
48.593
Interactive OC5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OC5

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 28.8147
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 2.6170
Est. PEG Ratio 2.5590
Market Cap (M EUR) 2,858.71
Shares Outstanding (M) 57.08
30 Day Average Volume 24
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.58%
Cash Dividend (AUD) 1.2700
Dividend Ex-Date 09/02/2014
5 Year Dividend Growth 12.31%
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OC5

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for OC5

Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.

Christopher Graham Roberts "Chris"President/CEONeville J MitchellCFO/Secretary
David MorrisChief Strategy OfficerChristopher M Smith "Chris"Pres:Americas
More Company Profile & Key Executives for OC5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil